DrugTimes has learned and confirmed that Dr. Yaning Wang, a senior industry expert who has worked for the US Food and Drug Administration (FDA) for 18 years and rose to the position of Director of the Quantitative Pharmacology Review Department in the Clinical Pharmacology Review Office, has left Createrna Science and Technology and founded a new company.。 Dr. Wang graduated from PekingUniversity in 1996 with a Bachelor's degree in Pharmacy, then obtained a Master's degree in Biochemistry from the National Doping Control Center in 1999, and obtained a dual degree in Doctor of Pharmacy and Master of Statistics from the University of Florida in 2003.。 Dr. Wang joined the FDA in 2003 and worked there for 18 years, from reviewer, senior reviewer, team leader, deputy director of science, acting director, to director of the Quantitative Pharmacology Review Department in the Clinical Pharmacology Review Office, until leaving the FDA in September 2021. During this period, Dr. Wang was responsible for quantitative pharmacology reviews, research projects, and policy formulation in all disease areas, and played a key role in the decision-making for the approval of new drugs for several major diseases.。